Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

R.C. Coombes; E. Hall; L.J. Gibson; R. Paridaens; J. Jassem; T. Delozier; S.E. Jones; I. Alvarez; G. Bertelli; O. Ortmann; A.S. Coates; E. Bajetta; D. Dodwell; R.E. Coleman; L.J. Fallowfield; E. Mickiewicz; J. Andersen; P.E. Lonning; G. Cocconi; A. Stewart; N.S. Stuart; C.F. Snowdon; M. Carpentieri; G. Massimini; J.M. Bliss

doi:10.1056/NEJMoa040331

Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

R.C. Coombes, E. Hall, L.J. Gibson, R. Paridaens, J. Jassem, T. Delozier, S.E. Jones, I. Alvarez, G. Bertelli, O. Ortmann, A.S. Coates, E. Bajetta, D. Dodwell, R.E. Coleman, L.J. Fallowfield, E. Mickiewicz, J. Andersen, P.E. Lonning, G. Cocconi, A. StewartN.S. Stuart, C.F. Snowdon, M. Carpentieri, G. Massimini, J.M. Bliss

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1081-1092
Journal	New England Journal of Medicine
Volume	350
Issue number	11
DOIs	https://doi.org/10.1056/NEJMoa040331
Publication status	Published - 11 Mar 2004

Keywords

MEDICINE
GENERAL & INTERNAL

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMoa040331

Cite this

Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., Coates, A. S., Bajetta, E., Dodwell, D., Coleman, R. E., Fallowfield, L. J., Mickiewicz, E., Andersen, J., Lonning, P. E., Cocconi, G., ... Bliss, J. M. (2004). Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350(11), 1081-1092. https://doi.org/10.1056/NEJMoa040331

@article{463e233c2e3340c2b33f810dae18fb69,

title = "Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.",

keywords = "MEDICINE, GENERAL \& INTERNAL",

author = "R.C. Coombes and E. Hall and L.J. Gibson and R. Paridaens and J. Jassem and T. Delozier and S.E. Jones and I. Alvarez and G. Bertelli and O. Ortmann and A.S. Coates and E. Bajetta and D. Dodwell and R.E. Coleman and L.J. Fallowfield and E. Mickiewicz and J. Andersen and P.E. Lonning and G. Cocconi and A. Stewart and N.S. Stuart and C.F. Snowdon and M. Carpentieri and G. Massimini and J.M. Bliss",

year = "2004",

month = mar,

day = "11",

doi = "10.1056/NEJMoa040331",

language = "English",

volume = "350",

pages = "1081--1092",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "11",

}

Coombes, RC, Hall, E, Gibson, LJ, Paridaens, R, Jassem, J, Delozier, T, Jones, SE, Alvarez, I, Bertelli, G, Ortmann, O, Coates, AS, Bajetta, E, Dodwell, D, Coleman, RE, Fallowfield, LJ, Mickiewicz, E, Andersen, J, Lonning, PE, Cocconi, G, Stewart, A, Stuart, NS, Snowdon, CF, Carpentieri, M, Massimini, G & Bliss, JM 2004, 'Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.', New England Journal of Medicine, vol. 350, no. 11, pp. 1081-1092. https://doi.org/10.1056/NEJMoa040331

TY - JOUR

T1 - Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

AU - Coombes, R.C.

AU - Hall, E.

AU - Gibson, L.J.

AU - Paridaens, R.

AU - Jassem, J.

AU - Delozier, T.

AU - Jones, S.E.

AU - Alvarez, I.

AU - Bertelli, G.

AU - Ortmann, O.

AU - Coates, A.S.

AU - Bajetta, E.

AU - Dodwell, D.

AU - Coleman, R.E.

AU - Fallowfield, L.J.

AU - Mickiewicz, E.

AU - Andersen, J.

AU - Lonning, P.E.

AU - Cocconi, G.

AU - Stewart, A.

AU - Stuart, N.S.

AU - Snowdon, C.F.

AU - Carpentieri, M.

AU - Massimini, G.

AU - Bliss, J.M.

PY - 2004/3/11

Y1 - 2004/3/11

KW - MEDICINE

KW - GENERAL & INTERNAL

U2 - 10.1056/NEJMoa040331

DO - 10.1056/NEJMoa040331

M3 - Article

SN - 0028-4793

VL - 350

SP - 1081

EP - 1092

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 11

ER -